4 ms·
This is complete misdirection though. It has no relevance to a biotech company. If the test is cheap and easy, then charities and governments will carry it into
by XorNot 12y ago
This is complete misdirection though. It has no relevance to a biotech company. If the test is cheap and easy, then charities and governments will carry it into Africa. There's no fiscal reason to pay people with foreign policy experience, because it has nothing to do with foreign policy. Its miles away from being relevant to the central technology, and African charity is not how one achieves a multi-billion valuation.